Luxembourg Cardiovascular Drug Industry Outlook 2022 - 2026

See how Luxembourg Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Sales of Beta Blocking Medicine in Luxembourg are expected to reach $4.5 million by 2026. This is a slight increase of 0.5% per year since 2021 when sales totalled $4.5 million. Since 2000, the Luxembourger market has grown by an average of 1.9% each year. In 2021, the country was ranked 23rd in the world, behind New Zealand's $4.5 million. Italy, Canada and Australia were ranked second, third and fourth respectively.

Luxembourg Cardiovascular Drug Market Data and Forecasts

How much will Luxembourg Cardiovascular Drug Market grow to 2026?

Forecast: Cardiac Glycosides Sales in Luxembourg
Forecast: Cardiovascular System Medicine Sales in Luxembourg
Forecast: Antihypertensive Medicine Sales in Luxembourg
Forecast: Antihypertensive Medicine Sales in Luxembourg
Forecast: Renin-Angiotensin System Medicine Sales in Luxembourg

Other Top Countries about Cardiovascular Drug